Quality of Life on Peritoneal Dialysis Versus Hemodialysis in China

Exclusion Criteria

• •1. Subjects who are HIV positive
• •2. Subjects who have already received maintenance dialysis. Subjects are not excluded if a functional dialysis access is present ≤4 weeks before Screening for back-up purposes or for acute treatment of life-threatening uremic symptoms, electrolyte abnormalities or fluid overload
• •3. Subjects who have an active infection or other condition that the Investigator determines may jeopardize their ability to receive either modality of dialysis treatment or would preclude participation in the study
• •4. Subjects who report a history of illicit drug use or a regular or daily alcohol consumption of ≥4 alcoholic drinks per day in the 2 years before Screening
• •5. Subjects who have previously received renal transplantation and are currently prescribed immunosuppressive therapy
• •6. Subjects who are currently using any investigational drug
• •7. Subjects who are currently enrolled in other clinical studies
• •8. Subjects who are unwilling or unable to fully comply with the visits and assessments required by the protocol
• •* Peritoneal dialysis: documented extensive intra-peritoneal adhesions or other conditions in which PD is contraindicated
• •* Hemodialysis: severe cardiac instability or other conditions in which HD is contraindicated
• •10. Subjects who have a malignancy requiring chemotherapy or radiation therapy
• •11. Subjects undergoing temporary dialysis treatment between the Screening visit and Day 1 visit that is expected to exceed 6 weeks in duration
• •12. Subjects who have a life expectancy of \< 48 weeks